| 000 | 02653 a2200769 4500 | ||
|---|---|---|---|
| 005 | 20250515000543.0 | ||
| 264 | 0 | _c20051221 | |
| 008 | 200512s 0 0 eng d | ||
| 022 | _a0364-5134 | ||
| 024 | 7 |
_a10.1002/ana.20580 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWu, Jie | |
| 245 | 0 | 0 |
_aElectrophysiological properties of human hypothalamic hamartomas. _h[electronic resource] |
| 260 |
_bAnnals of neurology _cSep 2005 |
||
| 300 |
_a371-82 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_a6-Cyano-7-nitroquinoxaline-2,3-dione _xpharmacology |
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnesthetics, Local _xpharmacology |
| 650 | 0 | 4 |
_aBicuculline _xanalogs & derivatives |
| 650 | 0 | 4 |
_aCadmium Chloride _xpharmacology |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 | _aElectrophysiology |
| 650 | 0 | 4 |
_aExcitatory Amino Acid Agonists _xpharmacology |
| 650 | 0 | 4 |
_aExcitatory Amino Acid Antagonists _xpharmacology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGABA Antagonists _xpharmacology |
| 650 | 0 | 4 |
_aGlial Fibrillary Acidic Protein _xmetabolism |
| 650 | 0 | 4 |
_aGlutamate Decarboxylase _xmetabolism |
| 650 | 0 | 4 |
_aGlutamic Acid _xpharmacology |
| 650 | 0 | 4 |
_aHamartoma _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypothalamus _xmetabolism |
| 650 | 0 | 4 |
_aImmunohistochemistry _xmethods |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 |
_aIsoenzymes _xmetabolism |
| 650 | 0 | 4 |
_aKainic Acid _xpharmacology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMembrane Potentials _xphysiology |
| 650 | 0 | 4 |
_aNeurons _xclassification |
| 650 | 0 | 4 |
_aPatch-Clamp Techniques _xmethods |
| 650 | 0 | 4 | _aPeriodicity |
| 650 | 0 | 4 |
_aPhosphopyruvate Hydratase _xmetabolism |
| 650 | 0 | 4 |
_aPotassium Channel Blockers _xpharmacology |
| 650 | 0 | 4 |
_aTetraethylammonium _xpharmacology |
| 650 | 0 | 4 |
_aTetrodotoxin _xpharmacology |
| 650 | 0 | 4 |
_aValine _xanalogs & derivatives |
| 650 | 0 | 4 |
_aalpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid _xpharmacology |
| 650 | 0 | 4 |
_agamma-Aminobutyric Acid _xpharmacology |
| 700 | 1 | _aXu, Lin | |
| 700 | 1 | _aKim, Do Young | |
| 700 | 1 | _aRho, Jong M | |
| 700 | 1 | _aSt John, Paul A | |
| 700 | 1 | _aLue, Lih-Fen | |
| 700 | 1 | _aCoons, Stephen | |
| 700 | 1 | _aEllsworth, Kevin | |
| 700 | 1 | _aNowak, Lee | |
| 700 | 1 | _aJohnson, Eric | |
| 700 | 1 | _aRekate, Harold | |
| 700 | 1 | _aKerrigan, John F | |
| 773 | 0 |
_tAnnals of neurology _gvol. 58 _gno. 3 _gp. 371-82 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/ana.20580 _zAvailable from publisher's website |
| 999 |
_c15766356 _d15766356 |
||